LNSR Q4 2022 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$10M-8.8% YoY

Gross Profit

$6M63.4% margin

Operating Income

-$3M-25.5% margin

Net Income

-$2M-24.3% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+32.1%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$56M

Total Liabilities

$14M

Stockholders' Equity

$42M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$11M	-8.8%
Gross Profit	$6M	$6M	+15.1%
Operating Income	-$3M	-$4M	+33.2%
Net Income	-$2M	-$4M	+36.2%

Revenue Segments

Product

$8M90%

Service

$832,00010%

Geographic Segments

UNITED STATES

$6M74%

Asia Excluding South Korea

$1M13%

Europe

$1M12%

Other Geographical Region

$129,0001%

KOREA, REPUBLIC OF

$10,0000%